Skip to main content
NCBI home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
letter
. 1987 Dec;79(12):1249–1258.

Update in Cancer Chemotherapy: Genitourinary Tract Cancer, Part 1

Jane C Wright
PMCID: PMC2625648  PMID: 3323538

Abstract

An update of the state of the art of cancer chemotherapeutic treatment of genitourinary tract cancer is described in this multi-part series. Included in the review are cancers of the kidney, bladder, prostate, testicle, ovary, uterus, vulva, and gestational trophoblastic neoplasms. Part 1 focuses on the kidney.

In this heterogeneous group of tumors, the major triumphs of cancer chemotherapy are in the control of the less common of these tumors, namely, gestational trophoblastic neoplasms in women, in combination with surgery in the control of the embryonal cell cancer of the testis in men, and in combination with surgery and radiation therapy in the control of the Wilms' tumor in children. Important progress is being made in the control of the other tumors of the genitourinary tract with the use of cancer chemotherapy.

Full text

PDF
1249

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLOOM H. J., WALLACE D. M. HORMONES AND THE KIDNEY: POSSIBLE THERAPEUTIC ROLE OF TESTOSTERONE IN A PATIENT WITH REGRESSION OF METASTASES FROM RENAL ADENOCARCINOMA. Br Med J. 1964 Aug 22;2(5407):476–480. doi: 10.1136/bmj.2.5407.474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bloom H. J. Adjuvant therapy for adenocarcinoma of the kidney: present position and prospects. Br J Urol. 1973 Jun;45(3):237–257. doi: 10.1111/j.1464-410x.1973.tb12151.x. [DOI] [PubMed] [Google Scholar]
  3. Bloom H. J. Proceedings: Hormone-induced and spontaneous regression of metastatic renal cancer. Cancer. 1973 Nov;32(5):1066–1071. doi: 10.1002/1097-0142(197311)32:5<1066::aid-cncr2820320507>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  4. Böttiger L. E. Prognosis in renal carcinoma. Cancer. 1970 Oct;26(4):780–787. doi: 10.1002/1097-0142(197010)26:4<780::aid-cncr2820260406>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  5. Carter S. K. Chemotherapy and genitourinary oncology. I. Bladder cancer. Cancer Treat Rev. 1978 Jun;5(2):85–93. doi: 10.1016/s0305-7372(78)80008-5. [DOI] [PubMed] [Google Scholar]
  6. Clayman R. V., Jr, Gonzalez R., Fraley E. E. Renal cancer invading the inferior vena cava: clinical review and anatomical approach. J Urol. 1980 Feb;123(2):157–163. doi: 10.1016/s0022-5347(17)55832-2. [DOI] [PubMed] [Google Scholar]
  7. Cox C. E., Lacy S. S., Montgomery W. G., Boyce W. H. Renal adenocarcinoma: 28-year review, with emphasis on rationale and feasibility of preoperative radiotherapy. J Urol. 1970 Jul;104(1):53–61. doi: 10.1016/s0022-5347(17)61670-7. [DOI] [PubMed] [Google Scholar]
  8. FLOCKS R. H., KADESKY M. C. Malignant neoplasms of the kidney; an analysis of 353 patients followed five years or more. J Urol. 1958 Feb;79(2):196–201. doi: 10.1016/S0022-5347(17)66258-X. [DOI] [PubMed] [Google Scholar]
  9. FOOT N. C., HUMPHREYS G. A., WHITMORE W. F. Renal tumors: pathology and prognosis in 295 cases. J Urol. 1951 Aug;66(2):190–200. doi: 10.1016/S0022-5347(17)74326-1. [DOI] [PubMed] [Google Scholar]
  10. Finney R. The value of radiotherapy in the treatment of hypernephroma--a clinical trial. Br J Urol. 1973 Jun;45(3):258–269. doi: 10.1111/j.1464-410x.1973.tb12152.x. [DOI] [PubMed] [Google Scholar]
  11. Golimbu M., Al-Askari S., Tessler A., Morales P. Aggressive treatment of metastatic renal cancer. J Urol. 1986 Oct;136(4):805–807. doi: 10.1016/s0022-5347(17)45085-3. [DOI] [PubMed] [Google Scholar]
  12. Holland J. M. Proceedings: Cancer of the kidney--natural history and staging. Cancer. 1973 Nov;32(5):1030–1042. doi: 10.1002/1097-0142(197311)32:5<1030::aid-cncr2820320502>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  13. Horn L., Horn H. L. An immunological approach to the therapy of cancer? Lancet. 1971 Aug 28;2(7722):466–469. doi: 10.1016/s0140-6736(71)92632-8. [DOI] [PubMed] [Google Scholar]
  14. Hrushesky W. J., Murphy G. P. Current status of the therapy of advanced renal carcinoma. J Surg Oncol. 1977;9(3):277–288. doi: 10.1002/jso.2930090310. [DOI] [PubMed] [Google Scholar]
  15. Humphrey L. J., Murray D. R., Boehm O. R. Effect of tumor vaccines in immunizing patients with cancer. Surg Gynecol Obstet. 1971 Mar;132(3):437–442. [PubMed] [Google Scholar]
  16. Kangarloo H., Dietrich R. B., Ehrlich R. M., Boechat M. I., Feig S. A. Magnetic resonance imaging of Wilms tumor. Urology. 1986 Sep;28(3):203–207. doi: 10.1016/0090-4295(86)90043-9. [DOI] [PubMed] [Google Scholar]
  17. Lokich J. J., Harrison J. H. Renal cell carcinoma: natural history and chemotherapeutic experience. J Urol. 1975 Sep;114(3):371–374. doi: 10.1016/s0022-5347(17)67032-0. [DOI] [PubMed] [Google Scholar]
  18. McCune C. S., Schapira D. V., Henshaw E. C. Specific immunotherapy of advanced renal carcinoma: evidence for the polyclonality of metastases. Cancer. 1981 Apr 15;47(8):1984–1987. doi: 10.1002/1097-0142(19810415)47:8<1984::aid-cncr2820470814>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  19. Middleton R. G. Surgery for metastatic renal cell carcinoma. J Urol. 1967 Jun;97(6):973–977. doi: 10.1016/S0022-5347(17)63157-4. [DOI] [PubMed] [Google Scholar]
  20. Montie J. E., Bukowski R. M., Deodhar S. H., Hewlett J. S., Stewart B. H., Straffon R. A. Immunotherapy of disseminated renal cell carcinoma with transfer factor. J Urol. 1977 May;117(5):553–556. doi: 10.1016/s0022-5347(17)58533-x. [DOI] [PubMed] [Google Scholar]
  21. Morales A., Wilson J. L., Pater J. L., Loeb M. Cytoreductive surgery and systemic bacillus Calmette-Guerin therapy in metastatic renal cancer: a phase II trial. J Urol. 1982 Feb;127(2):230–235. doi: 10.1016/s0022-5347(17)53713-1. [DOI] [PubMed] [Google Scholar]
  22. Myers G. H., Jr, Fehrenbaker L. G., Kelalis P. P. Prognostic significance of renal vein invasion by hypernephroma. J Urol. 1968 Oct;100(4):420–423. doi: 10.1016/s0022-5347(17)62543-6. [DOI] [PubMed] [Google Scholar]
  23. Peeling W. B., Mantell B. S., Shepheard B. G. Post-operative irradiation in the treatment of renal cell carcinoma. Br J Urol. 1969 Feb;41(1):23–31. doi: 10.1111/j.1464-410x.1969.tb09903.x. [DOI] [PubMed] [Google Scholar]
  24. Quesada J. R., Rios A., Swanson D., Trown P., Gutterman J. U. Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinoma. J Clin Oncol. 1985 Nov;3(11):1522–1528. doi: 10.1200/JCO.1985.3.11.1522. [DOI] [PubMed] [Google Scholar]
  25. Quesada J. R., Swanson D. A., Gutterman J. U. Phase II study of interferon alpha in metastatic renal-cell carcinoma: a progress report. J Clin Oncol. 1985 Aug;3(8):1086–1092. doi: 10.1200/JCO.1985.3.8.1086. [DOI] [PubMed] [Google Scholar]
  26. Quesada J. R., Swanson D. A., Trindade A., Gutterman J. U. Renal cell carcinoma: antitumor effects of leukocyte interferon. Cancer Res. 1983 Feb;43(2):940–947. [PubMed] [Google Scholar]
  27. RICHES E. W., GRIFFITHS I. H., THACKRAY A. C. New growths of the kidney and ureter. Br J Urol. 1951 Dec;23(4):297–356. doi: 10.1111/j.1464-410x.1951.tb03625.x. [DOI] [PubMed] [Google Scholar]
  28. ROBSON C. J. Radical nephrectomy for renal cell carcinoma. J Urol. 1963 Jan;89:37–42. doi: 10.1016/S0022-5347(17)64494-X. [DOI] [PubMed] [Google Scholar]
  29. Rafla S. Renal cell carcinoma. Natural history and results of treatment. Cancer. 1970 Jan;25(1):26–40. doi: 10.1002/1097-0142(197001)25:1<26::aid-cncr2820250106>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  30. Ramming K. P., deKernion J. B. Immune RNA therapy for renal cell carcinoma: survival and immunologic monitoring. Ann Surg. 1977 Oct;186(4):459–467. doi: 10.1097/00000658-197710000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Riches E. The place of irradiation. JAMA. 1968 Apr 15;204(3):230–231. [PubMed] [Google Scholar]
  32. Riches E. The place of radiotherapy in the management of parenchymal carcinoma of the kidney. J Urol. 1966 Mar;95(3):313–317. doi: 10.1016/S0022-5347(17)63453-0. [DOI] [PubMed] [Google Scholar]
  33. Richie J. P., Wang B. S., Steele G. D., Jr, Wilson R. E., Mannick J. A. In vivo and in vitro effects of xenogeneic immune ribonucleic acid in patients with advanced renal cell carcinoma: a phase I study. J Urol. 1981 Jul;126(1):24–28. doi: 10.1016/s0022-5347(17)54360-8. [DOI] [PubMed] [Google Scholar]
  34. Robson C. J., Churchill B. M., Anderson W. The results of radical nephrectomy for renal cell carcinoma. J Urol. 1969 Mar;101(3):297–301. doi: 10.1016/s0022-5347(17)62331-0. [DOI] [PubMed] [Google Scholar]
  35. Robson C. J., Churchill B. M., Anderson W. The results of radical nephrectomy for renal cell carcinoma. Trans Am Assoc Genitourin Surg. 1968;60:122–129. [PubMed] [Google Scholar]
  36. Rosenberg S. A., Lotze M. T., Muul L. M., Leitman S., Chang A. E., Ettinghausen S. E., Matory Y. L., Skibber J. M., Shiloni E., Vetto J. T. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med. 1985 Dec 5;313(23):1485–1492. doi: 10.1056/NEJM198512053132327. [DOI] [PubMed] [Google Scholar]
  37. Samuels M. L., Sullivan P., Howe C. D. Medroxyprogesterone acetate in the treatment of renal cell carcinoma (hypernephroma). Cancer. 1968 Sep;22(3):525–532. doi: 10.1002/1097-0142(196809)22:3<525::aid-cncr2820220306>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  38. Skinner D. G., Colvin R. B., Vermillion C. D., Pfister R. C., Leadbetter W. F. Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases. Cancer. 1971 Nov;28(5):1165–1177. doi: 10.1002/1097-0142(1971)28:5<1165::aid-cncr2820280513>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  39. Skinner D. G., Pfister R. F., Colvin R. Extension of renal cell carcinoma into the vena cava: the rationale for aggressive surgical management. J Urol. 1972 May;107(5):711–716. doi: 10.1016/s0022-5347(17)61122-4. [DOI] [PubMed] [Google Scholar]
  40. Swanson D. A., Johnson D. E., von Eschenbach A. C., Chuang V. P., Wallace S. Angioinfarction plus nephrectomy for metastatic renal cell carcinoma--an update. J Urol. 1983 Sep;130(3):449–452. doi: 10.1016/s0022-5347(17)51244-6. [DOI] [PubMed] [Google Scholar]
  41. Talley R. W. Proceedings: Chemotherapy of adenocarcinoma of the kidney. Cancer. 1973 Nov;32(5):1062–1065. doi: 10.1002/1097-0142(197311)32:5<1062::aid-cncr2820320506>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  42. Tykkä H. Active specific immunotherapy with supportive measures in the treatment of advanced palliatively nephrectomised renal adenocarcinoma. A controlled clinical study. Scand J Urol Nephrol Suppl. 1981;63:1–107. [PubMed] [Google Scholar]
  43. Umeda T., Niijima T. Phase II study of alpha interferon on renal cell carcinoma. Summary of three collaborative trials. Cancer. 1986 Sep 15;58(6):1231–1235. doi: 10.1002/1097-0142(19860915)58:6<1231::aid-cncr2820580610>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  44. Wagle D. G., Murphy G. P. Hormonal therapy in advanced renal cell carcinoma. Cancer. 1971 Aug;28(2):318–321. doi: 10.1002/1097-0142(197108)28:2<318::aid-cncr2820280209>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  45. van der Werf-Messing B. Proceedings: Carcinoma of the kidney. Cancer. 1973 Nov;32(5):1056–1061. doi: 10.1002/1097-0142(197311)32:5<1056::aid-cncr2820320505>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES